Navigation Links
Nventa to Present at Bio 2008 International Convention
Date:6/16/2008

SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today that the Company's vice president of corporate development, Richard Lai Fatt, Ph.D., is scheduled to present a Company overview at the Business Forum during the Biotechnology Industry Organization 2008 International Convention being held in San Diego, California, July 17-20, 2008. The presentation will take place on Wednesday, June 18, 2008, at 3:45 p.m. PDT in Room 5B at the San Diego Convention Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM023LOGO)

Dr. Lai Fatt will discuss the Company's progress with its lead product candidate, HspE7, a novel compound intended for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. The presentation will not be webcast.

About Nventa Biopharmaceuticals Corporation:

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The Company is publicly traded on the Toronto Stock Exchange under the symbol NVN.

For more information about Nventa Biopharmaceuticals Corporation, please visit the Company's website located at http://www.nventacorp.com.


'/>"/>
SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
2. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
3. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
4. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
6. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
7. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
8. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
9. Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia
10. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
11. Genetic Immunity to Present at 2008 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Resources Group finds that the market for colorectal cancer (CRC) ... in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers Squibb/Eli ... of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan and ...
(Date:8/28/2014)... , Aug. 28, 2014 Levi & ... commenced in the United States District Court for the ... of investors who purchased Galectin Therapeutics Inc. ("Galectin" or ... and July 28, 2014. For more information, ... alleges that during the Class Period the Company violated ...
(Date:8/28/2014)... -- Nonin Medical, Inc., the inventor of finger pulse ... announced that the Food and Drug Administration (FDA) has ... for use in the United States ... hub or kiosk through a USB connector and measures ... patients. The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Also Receives Patent Covering ARIKACE for Once-Daily Treatment of ... June 25 Cystic Fibrosis Foundation Therapeutics Inc., the ... a $2.2 million award to Transave Inc., for the ... antibiotic that aims to treat Pseudomonas lung ...
... , Study shows 4% CHG antiseptic is effective against a ... Ga., June 24 Hand washing with a 4% chlorhexidine ... to stop the spread of the H1N1 Swine Flu Virus. ... Personnel Hand Antiseptic Towelettes have been tested and found to ...
Cached Medicine Technology:Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Hand Washing with 4% CHG Antiseptic Kills Flu Viruses 2
(Date:8/29/2014)... 29, 2014 Williams Rejuva Center is ... their Latham aesthetic office. Dr. Edwin Williams, known ... the first surgeons in the area to employ the ... technique is faster and safer than similar products available ... a noninvasive procedure , designed to dramatically improve ...
(Date:8/29/2014)... Thompson HealthDay Reporter , THURSDAY, ... the early days of the Ebola outbreak in West Africa ... and spreads. Researchers report in the Aug. 28 online ... the following: The Ebola strains responsible for the ... the very first recorded outbreak of Ebola in central Africa ...
(Date:8/29/2014)... 2014 (HealthDay News) -- Researchers have discovered that people ... Dyslexia -- the most commonly diagnosed learning disorder ... and writing. Previous research showed that brain activity ... those studies focused only on a small number of ... to analyze how multiple brain regions use networks to ...
(Date:8/29/2014)... VHA Central Atlantic recognized Novant Health ... honoring nine facilities for meeting or exceeding national performance ... Health, providing quality, affordable healthcare for our communities has ... executive vice president and chief medical officer. “These awards ... for each and every one of our patients.” , ...
(Date:8/29/2014)... Port Washington, New York (PRWEB) August 29, 2014 ... that has long been dedicated to protecting the rights ... that the Drug Enforcement Administration (DEA) has announced new ... Regulatory Affairs Professionals Society (RAPS) report dated ... combination products as Schedule II drugs under federal law. ...
Breaking Medicine News(10 mins):Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3
... scientific study has backed them up by showing that dating, ... they really are. Researchers at the University of Alberta in ... Victoria, carried out the study. ,As a part ... 700 adolescents between 12 to 19 years of age from ...
... the killing last year of an unarmed man on his ... mandatory breathalyzer tests after such shootings. Sean Bell, a 23-year-old ... girlfriend, died in a hail of 50 bullets hours before ... fire on Bells car outside a topless bar. Two ...
... Kerala Tuesday remained glued to their seats in the assembly ... raging fever that has killed 76 people. ... the day. Our only demand is that the government should ... former chief minister Oommen Chandy, now leader of the United ...
... (IIT), Kharagpur, in West Bengal is the top technology ... which held the position last year, a survey ... Data Quest, a technology magazine in India, and International ... IITs have bagged the top seven positions. IIT-Kharagpur climbed ...
... Research from The University of Arizona Sarver Heart Center ... heart disease. Excessive body weight is associated ... left ventricle, the hearts pumping chamber. Known to physicians ... lead to heart failure and rhythm problems. ...
... from Princess Margaret Hospital (PMH) are using a new ... therapy , takes less than an hour and eliminates ... PMH team combined the expertise of surgeons, radiation medicine ... perform its first procedure. It marked the first time ...
Cached Medicine News:Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Breathalyzer Tests for Cops Involved in Shootings 2Health News:Kerala Opposition's Unique Protest Over Fever Deaths 2Health News:IIT-Kharagpur the Leading Technology College in India: Survey 2Health News:Interoperative Radiotherapy for Breast Cancer Patients 2
Hook Shaped Tip , Curved to the Left; with 30 cm long silicone tubing with connector; overall length 40mm; stainless steel...
... biopsy forceps are designed for endomyocardial biopsies. ... of a 3-pull ring handle, stainless steel cutting ... ring rotates to accommodate any position. ,A spring ... The jaws are opened by moving the double ...
The only solution for in-line digital measurement...
A highly precise stereotactic radiosurgery system for the treatment of intra-cranial lesions....
Medicine Products: